Liming Wang

1.8k total citations
62 papers, 663 citations indexed

About

Liming Wang is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Liming Wang has authored 62 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Surgery, 27 papers in Hepatology and 19 papers in Oncology. Recurrent topics in Liming Wang's work include Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Liming Wang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Liming Wang collaborates with scholars based in China, United States and Ethiopia. Liming Wang's co-authors include Jianxiong Wu, Weiqi Rong, Fan Wu, Weihu Wang, Bo Chen, Shengtao Lin, Quan Xu, Liguo Liu, Ye‐Xiong Li and Jun Yin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Liming Wang

59 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liming Wang China 15 292 252 197 148 132 62 663
Weiqi Rong China 18 490 1.7× 286 1.1× 234 1.2× 161 1.1× 203 1.5× 74 802
Yangxun Pan China 15 243 0.8× 149 0.6× 161 0.8× 70 0.5× 119 0.9× 55 492
Yabing Cao China 15 182 0.6× 131 0.5× 350 1.8× 191 1.3× 189 1.4× 52 811
Vincenzo Dadduzio Italy 18 297 1.0× 196 0.8× 451 2.3× 164 1.1× 99 0.8× 39 834
Pedro Luiz Serrano Usón Brazil 14 149 0.5× 181 0.7× 322 1.6× 102 0.7× 92 0.7× 59 584
Yoshihito Kotera Japan 15 441 1.5× 554 2.2× 375 1.9× 96 0.6× 187 1.4× 51 921
D. Jaeger Germany 10 191 0.7× 103 0.4× 370 1.9× 97 0.7× 54 0.4× 18 566
Dario Marino Italy 9 220 0.8× 90 0.4× 175 0.9× 117 0.8× 188 1.4× 31 534
Li‐Jian Liang China 17 535 1.8× 250 1.0× 474 2.4× 141 1.0× 292 2.2× 33 986

Countries citing papers authored by Liming Wang

Since Specialization
Citations

This map shows the geographic impact of Liming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liming Wang more than expected).

Fields of papers citing papers by Liming Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liming Wang. The network helps show where Liming Wang may publish in the future.

Co-authorship network of co-authors of Liming Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Liming Wang. A scholar is included among the top collaborators of Liming Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liming Wang. Liming Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Geng, Dawei, Zhong Chen, Yin Li, Tianbao Liu, & Liming Wang. (2024). Design and bio-evaluation of novel millepachine derivatives targeting tubulin colchicine binding site for treatment of osteosarcoma. Bioorganic Chemistry. 151. 107624–107624. 2 indexed citations
3.
Zhang, Jiajun, et al.. (2024). The cumulative antitumor effects of regorafenib and radiotherapy in hepatocellular carcinoma. Molecular Carcinogenesis. 63(9). 1738–1749. 2 indexed citations
4.
5.
6.
Huang, Wenting, et al.. (2023). Role of immunophenotypic characterisation in prognostic subtyping of intrahepatic cholangiocarcinoma. Pathology. 55(7). 979–988. 2 indexed citations
7.
Zhang, Jing, et al.. (2023). Role of NCF2 as a potential prognostic factor and immune infiltration indicator in hepatocellular carcinoma. Cancer Medicine. 12(7). 8991–9004. 11 indexed citations
8.
Zhang, Kai, Yue Liu, Liming Wang, et al.. (2023). Clinical benefits of intraoperative radiotherapy for the recurrence of centrally located hepatocellular carcinoma with microvascular invasion. Cancer Reports. 7(1). e1928–e1928. 3 indexed citations
9.
Chen, Bo, Hongzhi Wang, Yuting Zhao, et al.. (2023). Survival benefit of radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma: A propensity score-matched analysis based on phase II study. Radiotherapy and Oncology. 180. 109462–109462. 6 indexed citations
10.
Wu, Fan, Hongwei Wang, Liming Wang, et al.. (2023). Clinical Benefits of Neoadjuvant Radiotherapy on the Postoperative Recurrence of Centrally Located Hepatocellular Carcinoma: A Real-World Evidence Based on Phase II Clinical Trial. Journal of Hepatocellular Carcinoma. Volume 10. 753–764. 3 indexed citations
11.
Chen, Bo, Jianxiong Wu, Liming Wang, et al.. (2021). Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC. Hepatology. 74(5). 2595–2604. 48 indexed citations
12.
Sun, Yongkun, Aiping Zhou, Wen Zhang, et al.. (2021). Anlotinib in the treatment of advanced hepatocellular carcinoma: an open-label phase II study (ALTER-0802 study). Hepatology International. 15(3). 621–629. 41 indexed citations
13.
Wang, Liming, et al.. (2020). Enhanced recovery after surgery strategy for cirrhosis patients undergoing hepatectomy: experience in a single research center. Annals of Surgical Treatment and Research. 98(5). 224–224. 10 indexed citations
14.
Liu, Mei, et al.. (2020). Possible local treatment for liver metastases of adenoid cystic carcinoma (ACC): single-centre experience and literature review. Translational Cancer Research. 9(8). 4573–4582. 4 indexed citations
15.
16.
Wang, Liming, Bo Chen, Zhuo Li, et al.. (2019). <p>Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis</p>. OncoTargets and Therapy. Volume 12. 1237–1247. 19 indexed citations
17.
Wang, Liming, et al.. (2018). Regional Ischemic Preconditioning Has Clinical Value in Cirrhotic HCC Through MAPK Pathways. Journal of Gastrointestinal Surgery. 23(9). 1767–1777. 3 indexed citations
18.
Tian, Fei, Jianxiong Wu, Weiqi Rong, et al.. (2014). Retrospective Evaluation of Discrepancies between Radiological and Pathological Size of Hepatocellular Carcinoma Masses. Asian Pacific Journal of Cancer Prevention. 15(21). 9487–9494. 4 indexed citations
19.
Li, Qiong, Jun Yin, Xu Wang, et al.. (2013). B-cell Lymphoma 2 rs17757541 C>G Polymorphism was Associated with an Increased Risk of Gastric Cardiac Adenocarcinoma in a Chinese Population. Asian Pacific Journal of Cancer Prevention. 14(7). 4301–4306. 9 indexed citations
20.
Wang, Weihu, Weiqi Rong, Liming Wang, et al.. (2013). Adjuvant Radiotherapy in Centrally Located Hepatocellular Carcinomas after Hepatectomy with Narrow Margin (<1 cm): A Prospective Randomized Study. Journal of the American College of Surgeons. 218(3). 381–392. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weiqi Rong Breakdown of academic impact, for papers by Yangxun Pan Breakdown of academic impact, for papers by Yabing Cao Breakdown of academic impact, for papers by Vincenzo Dadduzio Breakdown of academic impact, for papers by Pedro Luiz Serrano Usón Breakdown of academic impact, for papers by Yoshihito Kotera Breakdown of academic impact, for papers by D. Jaeger Breakdown of academic impact, for papers by Dario Marino Breakdown of academic impact, for papers by Li‐Jian Liang
Rankless by CCL
2026